Cargando…
Development of Novel CD47-Specific ADCs Possessing High Potency Against Non-Small Cell Lung Cancer in vitro and in vivo
Targeted therapies hold promise for efficiently and accurately delivering cytotoxic drugs directly to tumor tissue to exert anticancer effects. CD47 is a membrane protein expressed in a variety of malignant tumors and hematopoietic cells, which plays a key role in immune escape and tumor progression...
Autores principales: | Chiang, Zu-Chian, Fang, Shubin, Shen, Yang-kun, Cui, Dongya, Weng, Huanjiao, Wang, Dawei, Zhao, Yuxiang, Lin, Jizhen, Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133542/ https://www.ncbi.nlm.nih.gov/pubmed/35646646 http://dx.doi.org/10.3389/fonc.2022.857927 |
Ejemplares similares
-
Ex vivo near-infrared targeted imaging of human bladder carcinoma by ICG-anti-CD47
por: Hao, Haifeng, et al.
Publicado: (2023) -
Targeting CD47 as a Novel Immunotherapy for Breast Cancer
por: Chen, Can, et al.
Publicado: (2022) -
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
por: Chao, Mark P., et al.
Publicado: (2020) -
A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021) -
Ex Vivo Near-Infrared Molecular Imaging of Human Upper Urinary Tract Urothelial Carcinoma With a CD47-Based Targeted Tracer
por: Yan, Pengyu, et al.
Publicado: (2022)